Advantage Investment Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,810
Closed -$10K 976
2018
Q4
$10K Hold
5,810
0.01% 653
2018
Q3
$36K Hold
5,810
0.02% 453
2018
Q2
$37K Hold
5,810
0.03% 420
2018
Q1
$41K Hold
5,810
0.02% 421
2017
Q4
$73K Hold
5,810
0.02% 338
2017
Q3
$69K Sell
5,810
-530
-8% -$7.86K 0.02% 332
2017
Q2
$95K Hold
6,340
0.03% 249
2017
Q1
$60K Sell
6,340
-216
-3% -$1.82K 0.02% 304
2016
Q4
$58K Sell
6,556
-1,870
-22% -$16.8K 0.02% 306
2016
Q3
$72K Sell
8,426
-4,118
-33% -$32.6K 0.03% 266
2016
Q2
$100K Sell
12,544
-941
-7% -$7.32K 0.05% 227
2016
Q1
$118K Hold
13,485
0.05% 193
2015
Q4
$126K Hold
13,485
0.07% 193
2015
Q3
$130K Hold
13,485
0.07% 166
2015
Q2
$156K Buy
+13,485
New +$139K 0.08% 168

Other funds holding MDXG

Advantage Investment Management's MDXG Position: Q1 2019 in Review

Advantage Investment Management sold out of MiMedx Group (MDXG) in Q1 2019, closing a stake of 5,810 shares — an estimated $10K sold.

Advantage Investment Management first reported a position in MDXG in Q2 2015 and held it in 15 quarters. The position peaked at $156K in Q2 2015. 18 funds tracked by Wall St. Rank hold MDXG as of Q1 2019.

  • Advantage Investment Management reported no remaining MiMedx Group position as of Q1 2019 after selling out during the quarter.
  • Advantage Investment Management sold 5,810 MiMedx Group shares in Q1 2019, an estimated $10K.
  • Advantage Investment Management first reported a position in MiMedx Group in Q2 2015 and held it in 15 quarters.
  • Advantage Investment Management's MiMedx Group position peaked at $156K in Q2 2015.
  • 18 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2019.

Based on Advantage Investment Management's 13F filing for Q1 2019, filed 15 May 2019.